Home / Share Price Target / Balpharma
Bal Pharma Share Price Target 2024, 2025, 2026 to 2039 With Charts
Bal Pharma Limited | |||
 | Symbol: BALPHARMA | ||
| Price: ₹120.55 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers—Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Bal Pharma Brief Company Overview
- 1.1: Bal Pharma: A Reputable Leader in Pharmaceuticals
- 1.2: Bal Pharma Financial Performance
- 1.2.1: Is Bal Pharma A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Bal Pharma Share Price Target For 2024
- 2.1.1: Bal Pharma Share Price Target Table For 2024
- 2.1.2: Summary: Bal Pharma Share Price Prediction For 2024
- 2.2: Bal Pharma Share Price Target For 2025
- 2.2.1: Bal Pharma Share Price Target Table For 2025
- 2.2.2: Summary: Bal Pharma Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Bal Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Bal Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Bal Pharma Past Performance
Bal Pharma Brief Company Overview
Bal Pharma: A Reputable Leader in Pharmaceuticals
Since its inception in 1987, Bal Pharma Limited has established itself as a trusted name in the pharmaceutical industry. Headquartered in Bengaluru, India, the company has a global presence in India, Uzbekistan, Guatemala, and Malta.
Product Range:- Prescription drugs
- Generics
- OTC products
- Intravenous infusion products
- Bulk actives
- Anti-infectives
- Pain management
- Respiratory care
- Women's health products
- Diabetic care products
- Herbal/ayurvedic preparations
- Anti-hypertensive, anti-lipidemic, and anti-obese products
- Skin care and bone health products
- Cardiac care products
Commitment: Bal Pharma is dedicated to providing high-quality products and services to improve patient health.
Advertisement
Bal Pharma Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 200.76 Crore | Market valuation of Bal Pharma's shares. |
| Revenue (TTM) | 343.19 Crore | Total revenue generated by Bal Pharma over the past twelve months. |
| Net Income (TTM) | +7.56 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 5.43% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 2.2% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | +5.6% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | +207.39% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 201.62 | Company's total debt divided by total shareholder equity. |
| Total Debt | 139.64 Crore | Sum of Bal Pharma's current & long-term financial obligations. |
| Total Cash | 20.04 Crore | Total amount of liquid funds available to Bal Pharma. |
| Beta | 0.55 | Beta is less than 1 indicating that the Bal Pharma's price is less volatile than the market. |
Is Bal Pharma A Good Buy For Long Term?
Bal Pharma, a small-cap stock with a market capitalization of ₹191.92 crore, presents a mixed picture for long-term investment. While its 12-month revenue reached ₹343.19 crore and it boasts impressive past returns (40.01% in the last year, 114.31% over three years), a low profit margin of 2.2% and significant debt (₹139.64 crore against ₹20.04 crore cash) raise concerns. The substantial year-on-year earnings increase (207.39%) warrants further investigation. Overall, it's an average buy, requiring deeper due diligence before committing to a long-term investment.
To predict the Bal Pharma's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Bal Pharma Share Price Target For 2024
The line chart displays the monthly closing prices of Bal Pharma with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Bal Pharma shares in 2024, see the table below.
Advertisement
Bal Pharma Share Price Target Table For 2024
| Bal Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 123.30 (+2.28%) | Price Action: Oct 2016 High |
| 2024 Target 2 | 122.00 (+1.2%) | Price Action: Mar 2022 High |
| 2024 Target 1 | 120.68 (+0.1%) | Fibonacci Extension Level 123.6% |
| Current Price | 120.55 | Bal Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 120.51 (-0.04%) | Price Action: Chart |
| Stop Loss 2 | 119.25 (-1.08%) | Price Action: Jun 2024 High |
| Stop Loss 3 | 118.00 (-2.12%) | Price Action: Nov 2016 High |
Summary: Bal Pharma Share Price Prediction For 2024
In summary, Bal Pharma has surged by ₹20.50, achieving a notable +20.49% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Bal Pharma for 2024 predicts an additional rise of 0.1% to 2.28% by the end of 2024 with three potential targets T1: 120.68, T2: 122.00, T3: 123.30. Stop Loss at SL1: 120.51, SL2: 119.25, SL3: 118.00.
Bal Pharma has a 52-week high of ₹157.97, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹88.95, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Bal Pharma.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Bal Pharma Share Price Target For 2025
The line chart displays the monthly closing prices of Bal Pharma with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Bal Pharma shares in 2025, see the table below.
Advertisement
Bal Pharma Share Price Target Table For 2025
| Bal Pharma's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 170.10 (+41.1%) | Price Action: Chart |
| 2025 Target 2 | 166.93 (+38.47%) | Fibonacci Extension Level 123.6% |
| 2025 Target 1 | 162.99 (+35.2%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 120.55 | Bal Pharma's 1 share price as of Thu 14 Nov 2024 |
| Stop Loss 1 | 109.75 (-8.96%) | Price Action: Aug 2021 High |
| Stop Loss 2 | 108.50 (-10%) | Price Action: Jun 2017 High |
| Stop Loss 3 | 107.00 (-11.25%) | Price Action: Jul 2021 High |
Summary: Bal Pharma Share Price Prediction For 2025
In summary, Bal Pharma has surged by ₹20.50, achieving a notable +20.49% increase from 1st January 2024 to 14 Nov 2024. Our analysis of Bal Pharma for 2025 predicts an additional rise of 35.2% to 41.1% by the end of 2025 with three potential targets T1: 162.99, T2: 166.93, T3: 170.10. Stop Loss at SL1: 109.75, SL2: 108.50, SL3: 107.00.
Bal Pharma has a All-Time high of ₹167.89, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹88.95, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Bal Pharma, we have created a specific page for that check here: Bal Pharma Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Bal Pharma Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Bal Pharma share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 8.51% over the next 15 years.
For complete year by year Bal Pharma long term share price target from 2024, 2025 to 2039 check the below table.
Bal Pharma Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Bal Pharma Target | YoY Change % |
|---|---|---|
| 2024 | ₹120.55 | [Current Price] |
| 2024 | ₹149.16 | 23.73% |
| 2025 | ₹157.91 | 5.86% |
| 2026 | ₹175.35 | 11.04% |
| 2027 | ₹198.79 | 13.36% |
| 2028 | ₹234.46 | 17.94% |
| 2029 | ₹268.51 | 14.52% |
| 2030 | ₹266.82 | -0.63% |
| 2031 | ₹281.63 | 5.55% |
| 2032 | ₹306.25 | 8.74% |
| 2033 | ₹348.84 | 13.9% |
| 2034 | ₹387.85 | 11.18% |
| 2035 | ₹375.73 | -3.13% |
| 2036 | ₹387.91 | 3.24% |
| 2037 | ₹413.72 | 6.65% |
| 2038 | ₹463.22 | 11.96% |
| 2039 | ₹467.73 | 0.97% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Bal Pharma Past Performance
- In 1995, Bal Pharma opening price was ₹22.15
- As of Thu 14 Nov 2024 the price stands at ₹120.55.
- This represents a Compound Annual Growth Rate (CAGR) of 5.81%.
- In 29 years, an investment of 10,000 would have become ₹54,424.37.
As we wrap up, we hope you like our study on Bal Pharma share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
